-
When early dropouts are classified as non-responders, Studies 009 and 011 meet the criteria for the categorical endpoint but Study 010 does not.
FORBES: Persistent Concerns About Lorcaserin (Lorqess) From FDA Reviewers
-
The study met its primary endpoint of durable response rate (DRR), defined as the rate of complete or partial response lasting continuously for at least six months.
FORBES: Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
-
The analysis of overall survival (OS), a key secondary endpoint of the study, is event driven.
FORBES: Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
-
The primary endpoint of the study is overall response rate.
FORBES: 7 Cancer Drug Stocks to Know Right Now
-
Therefore, the study did not meet its primary endpoint.
FORBES: Amgen's Vectibix Fails In Head-And-Neck Cancer
-
Merck announced today that the HPS2-THRIVE ( H eart P rotection S tudy 2- T reatment of H DL to R educe the I ncidence of V ascular E vents) study did not meet its primary endpoint.
FORBES: HPS2-THRIVE: No Benefit, Signal Of Harm For Niacin Therapy
-
Patients don't care if a drug meets the original primary endpoint of Dendreon's study, an improvement in X-rays, says Penson.
FORBES: Magazine Article
-
It's unlikely Schering and Merck knew the full results of the study and suppressed them, otherwise they would never have made a controversial decision to change the study's main goal or primary endpoint.
FORBES: Magazine Article
-
In other words, the study lost because of the choice of primary endpoint.
FORBES: Has Lipitor Reached Its Limit?
-
The press release issued last week said the study failed to show a benefit on the changed endpoint as well.
FORBES: Magazine Article
-
This study, however imperfect because of its focus on a surrogate endpoint, demonstrates why we need to generate more information about how drugs compare.
FORBES: AstraZeneca Study is Good News for the Public, Bad News for AstraZeneca
-
"The independent panel recommended focusing the primary endpoint to the common carotid artery to expedite the reporting of the study findings, " the companies said in a press release Nov. 19.
FORBES: Magazine Article